company background image
FIDS

Fidson HealthcareNGSE:FIDSON Stock Report

Market Cap

₦12.7b

7D

0.7%

1Y

64.0%

Updated

19 Oct, 2021

Data

Company Financials +
FIDSON fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance5/6
Financial Health3/6
Dividends3/6

FIDSON Overview

Fidson Healthcare Plc engages in the manufacture and distribution of pharmaceutical products in Nigeria.

Price History & Performance

Summary of all time highs, changes and price drops for Fidson Healthcare
Historical stock prices
Current Share Price₦6.10
52 Week High₦3.72
52 Week Low₦6.50
Beta0.26
1 Month Change0.16%
3 Month Change0.16%
1 Year Change63.98%
3 Year Change12.96%
5 Year Change342.03%
Change since IPO93.65%

Recent News & Updates

Shareholder Returns

FIDSONNG PharmaceuticalsNG Market
7D0.7%1.3%1.1%
1Y64.0%34.3%38.9%

Return vs Industry: FIDSON exceeded the NG Pharmaceuticals industry which returned 34.3% over the past year.

Return vs Market: FIDSON exceeded the NG Market which returned 38.9% over the past year.

Price Volatility

Is FIDSON's price volatile compared to industry and market?
FIDSON volatility
FIDSON Beta0.26
Industry Beta0.56
Market Beta1

Stable Share Price: FIDSON is less volatile than 75% of NG stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: FIDSON's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1995405Fidelis Ayebaehttps://www.fidson.com

Fidson Healthcare Plc engages in the manufacture and distribution of pharmaceutical products in Nigeria. The company operates through Over-the-Counter, Ethical Products, and Consumer segments. It offers drugs, injectables, and infusions.

Fidson Healthcare Fundamentals Summary

How do Fidson Healthcare's earnings and revenue compare to its market cap?
FIDSON fundamental statistics
Market Cap₦12.73b
Earnings (TTM)₦1.63b
Revenue (TTM)₦20.84b

7.8x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
FIDSON income statement (TTM)
Revenue₦20.84b
Cost of Revenue₦11.52b
Gross Profit₦9.33b
Expenses₦7.70b
Earnings₦1.63b

Dividends

4.1%

Current Dividend Yield

32%

Payout Ratio

Valuation

Is Fidson Healthcare undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: FIDSON (NGN6.1) is trading below our estimate of fair value (NGN93.24)

Significantly Below Fair Value: FIDSON is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: FIDSON is good value based on its PE Ratio (7.8x) compared to the African Pharmaceuticals industry average (9.4x).

PE vs Market: FIDSON is poor value based on its PE Ratio (7.8x) compared to the NG market (7.4x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate FIDSON's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: FIDSON is good value based on its PB Ratio (1.1x) compared to the XF Pharmaceuticals industry average (1.5x).


Future Growth

How is Fidson Healthcare forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

16.7%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if FIDSON's forecast earnings growth is above the savings rate (13.2%).

Earnings vs Market: Insufficient data to determine if FIDSON's earnings are forecast to grow faster than the NG market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: FIDSON's revenue (16.7% per year) is forecast to grow faster than the NG market (10.4% per year).

High Growth Revenue: FIDSON's revenue (16.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: FIDSON's Return on Equity is forecast to be high in 3 years time (23.7%)


Past Performance

How has Fidson Healthcare performed over the past 5 years?

5.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: FIDSON has high quality earnings.

Growing Profit Margin: FIDSON's current net profit margins (7.8%) are higher than last year (2.9%).


Past Earnings Growth Analysis

Earnings Trend: FIDSON's earnings have grown by 5.6% per year over the past 5 years.

Accelerating Growth: FIDSON's earnings growth over the past year (294.1%) exceeds its 5-year average (5.6% per year).

Earnings vs Industry: FIDSON earnings growth over the past year (294.1%) exceeded the Pharmaceuticals industry 10%.


Return on Equity

High ROE: FIDSON's Return on Equity (14.7%) is considered low.


Financial Health

How is Fidson Healthcare's financial position?


Financial Position Analysis

Short Term Liabilities: FIDSON's short term assets (NGN17.1B) exceed its short term liabilities (NGN11.9B).

Long Term Liabilities: FIDSON's short term assets (NGN17.1B) exceed its long term liabilities (NGN8.4B).


Debt to Equity History and Analysis

Debt Level: FIDSON's debt to equity ratio (120.6%) is considered high.

Reducing Debt: FIDSON's debt to equity ratio has increased from 43.9% to 120.6% over the past 5 years.

Debt Coverage: FIDSON's debt is well covered by operating cash flow (51.2%).

Interest Coverage: FIDSON's interest payments on its debt are not well covered by EBIT (2.8x coverage).


Balance Sheet


Dividend

What is Fidson Healthcare current dividend yield, its reliability and sustainability?

4.10%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: FIDSON's dividend (4.1%) is higher than the bottom 25% of dividend payers in the NG market (3.25%).

High Dividend: FIDSON's dividend (4.1%) is low compared to the top 25% of dividend payers in the NG market (7.24%).


Stability and Growth of Payments

Stable Dividend: FIDSON's dividend payments have been volatile in the past 10 years.

Growing Dividend: FIDSON's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (31.9%), FIDSON's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Fidelis Ayebae

no data

Tenure

Dr. Fidelis Akhagboso Ayebae serves as the Managing Director and Chief Executive Officer of Fidson Healthcare Plc. Dr. Ayebae has experience in corporate management having worked in Nigeria International B...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Fidson Healthcare Plc's employee growth, exchange listings and data sources


Key Information

  • Name: Fidson Healthcare Plc
  • Ticker: FIDSON
  • Exchange: NGSE
  • Founded: 1995
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₦12.727b
  • Shares outstanding: 2.09b
  • Website: https://www.fidson.com

Number of Employees


Location

  • Fidson Healthcare Plc
  • 268, Ikorodu Road
  • Obanikoro
  • Lagos
  • Nigeria

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/19 15:21
End of Day Share Price2021/10/18 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.